The transaction brings a complementary portfolio of products to Baker Hughes’ existing valves product line, expanding the company’s addressable market in the flow control market with the addition of CDC’s well-established critical pressure management solutions. The acquisition is expected to be immediately accretive to earnings and cash flow per share and Industrial & Energy Technology’s segment margins.